Physician profile
Daniel Perez
NPI 1215176086
$598.17
in general payments reported to CMS, 2019-2025
8 companies · $52.12 in 2025
The $52.12 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $54.04 · 2022: $166 · 2023: $186 · 2024: $139 · 2025: $52.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $378.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $377.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $156.99 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Integra Lifesciences Corporation | $120.29 | 2022 | |
| Smith+Nephew, INC. | $100.79 | 2022-2024 | Grafix Pl |
| Kowa Pharmaceuticals America, INC. | $99.68 | 2022-2024 | Livalo, Seglentis |
| Zimmer Biomet Holdings, INC. | $54.04 | 2021 | |
| Organogenesis INC. | $29.36 | 2024 | Puraply Wound Matrix |
| Exact Sciences Corporation | $23.74 | 2024 | Cologuard Collection Kit |
| Melinta Therapeutics, LLC | $13.28 | 2023 | Vabomere, Kimyrsa, Rezzayo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Perez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.